Dhaliwal Harpreet S.
Reporting owner on Forms 3, 4 and 5, CIK 1886794.
Dhaliwal Harpreet S. reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-13.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| PCVX · Vaxcyte, Inc.CIK 1649094 | officer (Chief Technical Ops Officer) | 1 | 2026-11-13 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| PCVX · Vaxcyte, Inc.Common Stock | 2026-11-11 | M exercised | +17,000 | $24.79 | 85,085 | Form 4 |
| PCVX · Vaxcyte, Inc.Common Stock | 2026-11-11 | S sold | -7,135 | $67.33 | 77,950 | Form 4 |
| PCVX · Vaxcyte, Inc.Common Stock | 2026-11-11 | S sold | -9,345 | $68.156 | 68,605 | Form 4 |
| PCVX · Vaxcyte, Inc.Common Stock | 2026-11-11 | S sold | -520 | $68.819 | 68,085 | Form 4 |
| PCVX · Vaxcyte, Inc.Stock Option (right to buy), derivative | 2026-11-11 | M exercised | -17,000 | $0 | 11,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001886794-26-000014 | Vaxcyte, Inc. | 2026-11-13 |